Common Contracts
2 similar Investor Rights Agreement contracts by Fate Therapeutics Inc
FATE THERAPEUTICS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • August 14th, 2013 • Fate Therapeutics Inc • Biological products, (no disgnostic substances) • Delaware
This Amended and Restated Investor Rights Agreement (the “Agreement”) is made as of August 8, 2013, among Fate Therapeutics, Inc., a Delaware corporation (the “Company”), the stockholders and holders of the Notes (as defined below) listed on Exhibit A hereto (each, an “Investor” and collectively, the “Investors”) and the stockholders and founders of the Company listed on Exhibit B hereto (each, a “Founder” and collectively, the “Founders”).
FATE THERAPEUTICS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • June 20th, 2013 • Fate Therapeutics Inc • Biological products, (no disgnostic substances) • Delaware
This Amended and Restated Investor Rights Agreement (the “Agreement”) is made as of June 18, 2013, among Fate Therapeutics, Inc., a Delaware corporation (the “Company”), the stockholders listed on Exhibit A hereto (each, an “Investor” and collectively, the “Investors”) and the stockholders and founders of the Company listed on Exhibit B hereto (each, a “Founder” and collectively, the “Founders”).
